Delivery Order SPE2DB20D2014-SPE2DB24FA98M

Award Date 2/3/24
Potential Completion Date 2/5/24
Potential Value $3.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a $3,860.28 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The order is for the supply of the MENVEO A-C-Y-W KIT (2 VIALS)S pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is not associated with any set-aside designation. The company also holds an...
This federal contract award, valued at $30,212.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of October 16, 2023 and is a firm fixed price agreement. The contract is not associated with a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Menveo A-C-Y-W-135-DIP vial kits. The $1,686.95 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $215,563.68 firm-fixed-price delivery order is for the supply of 4,565,827,894 units of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceutical product. The contract, which has a completion date of September 17, 2024, does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor in the United States, has been awarded...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $12,087.93 firm fixed price delivery order is for the supply of 4,563,946,912 doses of the MENVEO VACCINE VL 5S. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML. The firm fixed price contract has a potential value of $2,114.19 and a period of performance through February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. The contract is part of a larger DLA...
This federal contract award, valued at $8,172.79, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order for the MENVEO VACCINE VL 5S, a pharmaceutical product. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Amerisourcebergen Corporation) is a delivery order valued at $81,957.60 for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceutical products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $1,586.50, is a firm fixed price delivery order for the supply of 4564041176 - MENVEO A-C-Y-W KIT (2 VIALS). The contract has no set-aside designation and has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
This federal contract award, valued at $106,555.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) and has a Firm Fixed Price pricing type. The contract covers the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a completion date of May 1, 2024. This award was made through full and open competition, with no set-aside...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FA98M
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The $3,079.34 firm fixed price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. This award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, to provide a comprehensive range of pharmaceuticals and medical supplies to support Department of Defense military treatment facilities and programs worldwide. The parent company of the prime contractor, Amerisourcebergen Drug Corp, is Cencora, Inc., which does business as Amerisourcebergen.

Generated 5/4/24, 9:37 AM